Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminium magnesium carbonate, commonly known as hydrotalcite, is a small molecule antacid used for the symptomatic relief of conditions associated with gastric hyperacidity, such as heartburn, acid reflux, and dyspepsia. Manufactured by Hainan Miaoyinchun, this medication is formulated as a chewable tablet for oral administration. Its mechanism of action involves the chemical neutralization of gastric hydrochloric acid, which raises the pH of the stomach contents. This action helps to protect the gastric mucosa and alleviate pain and discomfort associated with hyperacidity. It is commonly indicated for the treatment of acute and chronic gastritis, as well as gastric and duodenal ulcers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium magnesium carbonate.